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Introduction
Prostate cancer is a common cancer in men. In America,
218,890 cases are diagnosed and 27,050 deaths occur
annually.1 In Taiwan, prostate cancer is the 6th most
common cancer in males, and its incidence rose to 14
per 105 in the year 2000.2 The clinical behavior of pros-
tate cancer ranges from a microscopic, well-differentiated
tumor to an aggressive cancer with substantial invasive
and metastatic potential. The most common metastatic
targets for prostate cancer include lymph nodes, bone,
lung and liver.3 Metastasis to the small intestine is an
unusual phenomenon of prostate cancer, but it can
elicit several gastrointestinal complications, such as
bleeding or obstruction. Herein, we present a case of
small intestine tumor caused by metastasis of prostate
cancer.
Case Report
An 81-year-old man had a history of benign prostate
hyperplasia for 10 years. He came to our hospital due
to symptoms of abdominal fullness and urine retention
of 1 month’s duration in April 2007. He had no his-
tory of dysuria or body weight loss. Laboratory workup
demonstrated microscopic hematuria by urinary analy-
sis and a high level of prostate-specific antigen (PSA)
up to 44.9 ng/mL (normal, < 4.0 ng/mL). Abdominal
computed tomography (CT) detected enlargement of
the prostate gland to about 5.3 cm in diameter with
low attenuation nodules (Figure 1A). Transurethral
resection of the prostate was performed, and biopsy
reported adenocarcinoma without perineural invasion.
Gleason’s score was 5 + 5 (Figure 2A). Bone scan study
found no definite evidence of bone metastasis. The
initial stage was T2N0M0, and the patient was later
discharged from our hospital and received radiother-
apy of the prostate gland for 2 months with a total
dose of 4,680 cGy, which was followed by continuous
hormone therapy. PSA level ranged from 2 ng/mL to
4 ng/mL.
The patient was brought to our hospital in April
2008 due to symptoms of abdominal fullness, poor ap-
petite and body weight loss of 10 kg over a period of
2 months. He had no history of cough, oligouria, ab-
dominal pain or tarry stool. Laboratory workup detected
nonspecific findings except for an elevated PSA level
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of 9.20 ng/mL. Upper endoscopy showed a single
soft tumor with hyperemic mucosal change in the sec-
ondary portion of the duodenum complicated with
partial lumen narrowing (Figure 3), and biopsy demon-
strated duodenal tissue with poorly differentiated car-
cinoma with positive PSA cytoplasmic stain. The
morphology of the duodenal tumor was similar to the
previous prostate pathologic appearance and was con-
sistent with prostate cancer metastasis to the small
bowel (Figures 2B–D). Abdominal CT demonstrated
only mild enlargement of the prostate gland, but showed
enlarged retroperitoneal lymph nodes and multiple
liver tumors with probable duodenal invasion (Figure
1B). Bone scan study did not detect any evidence of
bone metastasis.
The patient was later discharged from hospital and
received clinical follow-up. No further aggressive treat-
ment was administered due to patient refusal.
Discussion
The incidence of prostate cancer has been increasing
rapidly. The clinical course of prostate cancer ranges
from a well-differentiated and localized tumor to an
invasive and metastatic cancer. The predictive factors
for prognosis can be estimated by American Joint
Committee on Cancer (AJCC) staging criteria and
Gleason’s score.4
The Gleason grading system is based on the archi-
tectural features of prostate cancer cells, and an in-
creasing percentage of high-grade tumor is associated
with a statistically significant poorer cancer specific
survival rate.5 Metastases are more common in pa-
tients with poorly differentiated lesions and are usu-
ally seen in tumors that penetrate the capsule.6 In our
patient, the pathologic prostate appearance showed a
poorly differentiated carcinoma in a solid sheet pat-
tern without perineural invasion, which is consistent
with AJCC stage T2 and Gleason’s score 10 (5 + 5).
The finding of typical PSA histological patterns in 
the duodenal tumor is highly suggestive of prostatic
origin.
As the survival period of patients with prostate
cancer is prolonged, some unusual metastatic sites
caused from the origin of prostate cancer have been
identified. However, there have been no cases of
metastasis to the small intestine except for a single
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Figure 1. (A) Abdominal computed tomography in April 2007 shows an enlarged prostate gland with low attenuation nodules. 
(B) Abdominal computed tomography 1 year later in April 2008 shows progression to retroperitoneal lymph node and liver metastasis
with duodenal invasion (arrows).
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Prostate cancer metastasis to small intestine
previous case report; in 2001, Narveet reported a case
of a 69-year-old man with a history of prostate can-
cer, stage T3, and subsequent radical prostatectomy
and radiotherapy. He had malignant periportal lym-
phadenopathy 6 years afterwards, and received upper
endoscopy 9 years later due to symptoms of anasarca.
Visual inspection of the gastroduodenal mucosa was
normal, but biopsy of duodenal mucosa detected
infiltrating adenocarcinoma with a positive PSA stain.7
The findings of the upper endoscopy was not similar
to our patient’s. The solitary duodenal tumor found
in our patient may be due to direct invasion from 
a neighboring liver tumor rather than lymphatic
metastasis.
According to a previous survey, the lymphatic drain-
age of the prostate determines the location of the initial
metastases, but the subsequent widespread metastases
probably originate from the sentinel node.6 Although
prostate cancer can metastasize to almost any site in
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Figure 2. Pathology of the prostate gland and duodenal tumor. (A) Primary tumor in prostate is poorly differentiated carcinoma with a
solid sheet pattern without glandular lumen, Gleason grade 5 (hematoxylin & eosin, 400×). (B) Duodenal mucosa shows lymphatic
tumor thrombus in the mucosal lymphatic duct (hematoxylin & eosin, 400×). (C) Biopsy of duodenal tumor shows poorly differentiated
carcinoma in sheet-like growth pattern and single-cell infiltration. Normal intestinal villi can be seen on the left (hematoxylin & eosin,
400×). (D) Prostate-specific antigen cytoplasmic stain in tumor cells of the duodenal biopsy (immunohistochemical stain, 400×).
Figure 3. Upper endoscopy shows a soft tumor (arrows) in the
secondary portion of the duodenum with partial lumen narrowing.
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the body, the lymph nodes and bone remain the most
common sites.5 A study in 1986 of 89 autopsies of
prostate cancer patients showed metastasis to serosa,
liver, and large bowel accounting for 37%, 30%, and
13%, respectively.8 A more recent study in 2008 that
included 191 autopsies demonstrated that the 5 most
common metastatic targets for prostate cancer were the
regional lymph nodes (26.2%), bone (19.7%), distant
lymph nodes (18.4%), lung (12.8%), and liver (7.8%).3
However, a study in 2004 documented 2 cases of
small intestine involvement out of a total of 30 autop-
sies with primary prostate cancer.9 Therefore, small
intestine metastasis should not be ignored in patients
with advanced prostate cancer.
In conclusion, we have reported an unusual case
of a patient with metastatic duodenal tumor caused
by primary prostate cancer. This case should help
raise clinical awareness of the possibility of unusual
metastatic sites in patients with primary prostate 
cancer.
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